Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 216 (7%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2799 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LITHIUM CARBONATE | 150MG | CAPSULE | Resolved | 2024-04-19 | 2024-05-22 | 225802 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2024-01-19 | 2024-05-22 | 216669 |
| APO-TAMOX TAB 20MG | 20MG | TABLET | Resolved | 2024-04-12 | 2024-05-24 | 224990 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-05-03 | 2024-05-24 | 227088 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-05-10 | 2024-05-24 | 227725 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2024-03-08 | 2024-05-24 | 221696 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2024-04-12 | 2024-05-24 | 225011 |
| APO-BACLOFEN | 20MG | TABLET | Resolved | 2024-03-15 | 2024-05-24 | 222455 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2024-04-19 | 2024-05-24 | 225796 |
| APO-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-05-03 | 2024-05-24 | 227073 |
| APO-MIDODRINE | 5MG | TABLET | Resolved | 2024-01-26 | 2024-05-24 | 217472 |
| APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2024-02-09 | 2024-05-24 | 219162 |
| APO-MIRTAZAPINE | 45MG | TABLET | Resolved | 2024-04-26 | 2024-05-24 | 226333 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2024-04-12 | 2024-05-24 | 225002 |
| APO-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-04-12 | 2024-05-24 | 225008 |
| APO-VARENICLINE | 1MG | TABLET | Actual shortage | 2024-04-19 | 2024-05-24 | 225764 |
| APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2024-04-12 | 2024-05-24 | 225017 |
| APO-VALACYCLOVIR | 1000MG | TABLET | Actual shortage | 2024-05-10 | 2024-05-24 | 227714 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60769 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
| APO-DONEPEZIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60453 |
| APO-TADALAFIL | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-02-13 | 61045 |
| APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Discontinued | 2018-09-07 | 2019-02-13 | 60426 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
| APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
| APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 |